COVID-19 Vaccine Access Restricted for Children Amid FDA Guidance Shuffle

Strategic Insights -

As the Food and Drug Administration (FDA) restricts access to the COVID-19 vaccine for children due to conflicting guidance from Health Secretary Robert F. Kennedy Jr., pediatricians and health experts are expressing concerns about the potential for reduced vaccine availability and its impact on public health. The FDA's new recommendation limits the vaccine to individuals 65 and older and those between 5 and 64 with underlying health conditions placing them at high risk for severe COVID-19.

Key Takeaways:

  • The FDA's new guidance restricts access to the COVID-19 vaccine for children, citing concerns about the vaccine's effectiveness and potential complications.
  • Pediatrician Dr. Molly O'Shea notes that the FDA's decision does not reflect any changes in vaccine complications or effectiveness, and instead appears to be driven by conflicting guidance from Health Secretary Robert F. Kennedy Jr.
  • Dr. O'Shea emphasizes that vaccines are the safest and most effective way for the immune system to learn how to respond to a virus, and that restricting access to the vaccine can promote a mindset that the vaccine is not of value.
  • According to Dr. O'Shea, healthcare providers may be able to prescribe the vaccine for off-label use, either in-office or through a pharmacy, but this raises concerns about liability and the potential for adverse reactions.
  • The American Academy of Pediatrics recommends that all children 6 to 23 months old receive the vaccine, and for children 2 to 18 years old at high risk or whose parents desire to protect them from the illness.
  • Dr. O'Shea advises parents who want to ensure their children receive the vaccine to contact their local health department, which has committed to not turning anyone away who wants to receive the vaccine.

Statistics:

  • According to the FDA, the new guidance restricts access to the COVID-19 vaccine, limiting it to individuals 65 and older and those between 5 and 64 with underlying health conditions.
  • The Centers for Disease Control and Prevention (CDC) no longer recommends COVID-19 vaccination for children ranging from 6 months to 17 years of age.
  • A publication from the American Academy of Pediatrics notes that clinicians prescribing the vaccine could have two layers of protection, stemming from malpractice insurance and the PREP Act, which provides broad immunity from state and federal liability.
  • The New England Journal of Medicine has published an article on qualifying underlying conditions for the vaccine, including asthma, diabetes, cerebrovascular disorder, chronic kidney disease, chronic lung disease, chronic liver disease, heart conditions, certain mental health disorders, and more.

Sources:

  • [FDA approved updated vaccines for COVID-19](https://www.axios.com/2025/08/27/covid-vaccine-2025-fda-recommendation-rfk?utm_source=newsletter&utm_medium=email&utm_campaign=newsletter_axiospm&stream=top)
  • [Pediatricians new COVID-19 shot recommendations differ from CDC advice](https://www.nbcnews.com/health/health-news/us-pediatricians-new-covid-19-shot-recommendations-differ-cdc-advice-rcna225787)
  • [Hospitalization for COVID-19 and Risk Factors for Pediatric Patients](https://publications.aap.org/pediatrics/article/156/3/e2025072788/202525/Hospitalization-for-COVID-19-and-Risk-Factors-for)